Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-11-15
1994-04-26
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Lymphokine
514 2, 514 8, 530403, 435 701, 435 5, 4352402, 4352401, A61K 3912, C12N 506, C12P 2100
Patent
active
053064933
ABSTRACT:
Crandell feline kidney cells infected with a Rickard isolate of FeLV, i.e., FeLV-A.sub.R1, are provided, the infected cells being capable of producing viral materials in amounts sufficient for formulating FeLV vaccines. Processes for producing viral material and FeLV vaccines utilizing the viral material thus prepared also are provided.
REFERENCES:
patent: 3966907 (1976-06-01), Jarrett et al.
patent: 4034081 (1977-07-01), Jarrett et al.
patent: 4086134 (1978-04-01), Jarrett et al.
patent: 4117112 (1978-09-01), Jarrett et al.
patent: 4264587 (1981-04-01), Pedersen et al.
patent: 4332793 (1982-06-01), Olson
patent: 4699785 (1987-10-01), Pedersen
patent: 4772466 (1988-09-01), Allison et al.
Crandell et al., In Vitro, vol. 9, No. 3, (1973), pp. 176-185.
Park et al., Misaengmul Hakhoe Chi, (1983), vol. 21(2), pp. 61-70, [Chem. Abs. vol. 99 No. 136704j].
Sarma & Log, Virology (1973) 54:160-169.
Russell & Jarrett, Int'l J. Cancer (1978) 21:768-778.
Jarrett (1980), Feline Leukemia Virus--Developments in Cancer Research vol. 4, pp. 473-479.
Jarrett & Russell, Int'l Cancer, 1978 21:466-472.
Sarma et al., J. Nat'l Cancer Inst. (1978) 60:871-874.
Schaller & Olsen, Infect. Immun. (1975) 12:1405-1510.
Bass Edmund P.
Kelsey William H.
Cashion Jr. Merrell C.
Gil Joseph C.
Miles Inc.
Wessendorf T. D.
Whalen Lyndanne M.
LandOfFree
FeLV-infected feline cell line does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with FeLV-infected feline cell line, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FeLV-infected feline cell line will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1710421